We studied COVID-19 associated mucormycosis based on 17 cases reported nationwide and assessed the differences with India. They differed by frequencies of diabetes mellitus (47% in France versus up to 95% in India), hematological malignancies (35% versus 1%), anatomical sites (12% versus >80% rhino-orbito-cerebral) and prognosis (88% mortality versus <50%).
CITATION STYLE
Danion, F., Letscher-Bru, V., Guitard, J., Sitbon, K., Dellière, S., Angoulvant, A., … Alanio, A. (2022). Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication. Open Forum Infectious Diseases, 9(2). https://doi.org/10.1093/ofid/ofab566
Mendeley helps you to discover research relevant for your work.